Evidence map›Paper›PMID 36522646›Full record

ArticleJournal of neuroengineering and rehabilitation2022

Design and validation of a multi-task, multi-context protocol for real-world gait simulation.

Kirsty Scott, Tecla Bonci, Francesca Salis, Lisa Alcock, Ellen Buckley, Eran Gazit, Clint Hansen, Lars Schwickert, Kamiar Aminian, Stefano Bertuletti and 35 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroengineering and rehabilitation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Sensors in Multiple Sclerosis.Current neurology and neuroscience reports · 2025
    Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 9 countries.

Kirsty ScottDepartment of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK. kscott3@sheffield.ac.uk.
Tecla BonciDepartment of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK.
Francesca SalisDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.
Lisa AlcockTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Ellen BuckleyDepartment of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK.
Eran GazitCenter for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Clint HansenDepartment of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
Lars SchwickertRobert Bosch Gesellschaft für Medizinische Forschung, Stuttgart, Germany.
Kamiar AminianLaboratory of Movement Analysis and Measurement, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
Stefano BertulettiDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.
Marco CarusoDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.
Lorenzo ChiariDepartment of Electrical, Electronic and Information Engineering «Guglielmo Marconi», University of Bologna, Bologna, Italy.
Basil SharrackDepartment of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Walter MaetzlerDepartment of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
Clemens BeckerRobert Bosch Gesellschaft für Medizinische Forschung, Stuttgart, Germany.
Jeffrey M HausdorffCenter for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ioannis VogiatzisDepartment of Sport, Exercise and Rehabilitation, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Philip BrownNewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Silvia Del DinTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Björn EskofierMachine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Anisoara Paraschiv-IonescuLaboratory of Movement Analysis and Measurement, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
Alison KeoghInsight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
Cameron KirkTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Felix KlugeMachine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Encarna M Micó-AmigoTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Arne MuellerNovartis Institutes of Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
Isabel NeatrourTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Martijn NiessenMcRoberts BV, The Hague, The Netherlands.
Luca PalmeriniDepartment of Electrical, Electronic and Information Engineering «Guglielmo Marconi», University of Bologna, Bologna, Italy.
Henrik SillenDigital Health R&D, AstraZeneca, Sweden.
David SingletonInsight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
Martin UllrichMachine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Beatrix VereijkenDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
Marcel FroehlichGrünenthal GmbH, Aachen, Germany.
Gavin BrittainDepartment of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Brian CaulfieldInsight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
Sarah KochBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Anne-Elie CarsinBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Judith Garcia-AymerichBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Arne KuederleMachine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Alison YarnallTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Lynn RochesterTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Andrea CereattiDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.
Claudia MazzàDepartment of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK.
Mobilise-D consortium
Newcastle University · GBFriedrich-Alexander-Universität Erlangen-Nürnberg · DEInsigneo · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity College Dublin · IEBarcelona Institute for Global Health · ESÉcole Polytechnique Fédérale de Lausanne · CHNovartis (Switzerland) · CHPolytechnic University of Turin · ITRobert Bosch Stiftung · DESheffield Teaching Hospitals NHS Foundation Trust · GBTel Aviv Sourasky Medical Center · ILUniversity of Sassari · ITAstraZeneca (Sweden) · SEGrünenthal Group (Germany) · DELaboratori Guglielmo Marconi (Italy) · ITNorthumbria University · GBNorwegian University of Science and Technology · NOPompeu Fabra University · ESUniversity of Bologna · IT

Funding

Department of Health IS-BRC-1215–20017Department of Health IS-BRC-1215-2017Medical Research Council MC_PC_19047Wellcome Trust
6 · The paper itself

Abstract

backgroundMeasuring mobility in daily life entails dealing with confounding factors arising from multiple sources, including pathological characteristics, patient specific walking strategies, environment/context, and purpose of the task. The primary aim of this study is to propose and validate a protocol for simulating real-world gait accounting for all these factors within a single set of observations, while ensuring minimisation of participant burden and safety.

methodsThe protocol included eight motor tasks at varying speed, incline/steps, surface, path shape, cognitive demand, and included postures that may abruptly alter the participants' strategy of walking. It was deployed in a convenience sample of 108 participants recruited from six cohorts that included older healthy adults (HA) and participants with potentially altered mobility due to Parkinson's disease (PD), multiple sclerosis (MS), proximal femoral fracture (PFF), chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF). A novelty introduced in the protocol was the tiered approach to increase difficulty both within the same task (e.g., by allowing use of aids or armrests) and across tasks.

resultsThe protocol proved to be safe and feasible (all participants could complete it and no adverse events were recorded) and the addition of the more complex tasks allowed a much greater spread in walking speeds to be achieved compared to standard straight walking trials. Furthermore, it allowed a representation of a variety of daily life relevant mobility aspects and can therefore be used for the validation of monitoring devices used in real life.

conclusionsThe protocol allowed for measuring gait in a variety of pathological conditions suggests that it can also be used to detect changes in gait due to, for example, the onset or progression of a disease, or due to therapy.

trial registrationISRCTN-12246987.

Indexed as

GaitParkinson DiseaseAdultHumansResearch DesignWalkingWalking SpeedDigital mobility outcomesMobility monitoringNeurological diseasesTechnical validationWearable sensors

Identifiers

PMID36522646
PMCPMC9754996
OpenAlexW4311595507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.